Resources
Collateral Name or Title

Description if any

Prospera Specification Sheet

Reliable, Broad Assessment of Active Rejection

Publications
Analytical Validation of a Single-Nucleotide Polymorphism-Based Donor-Derived Cell-Free DNA Assay for Detecting Rejection in Kidney Transplant Patients

This study validates the performance of a SNP-based mmPCR assay to detect the dd-cfDNA fraction with improved precision over currently available tests, regardless of donor-recipient relationships...

Altug, Y.

Transplantation. 2019 Feb 19.

Optimizing Detection of Kidney Transplant Injury by Assessment of Donor-Derived Cell-Free DNA via Massively Multiplex PCR

This study validates the use of dd-cfDNA in the blood as an accurate marker of kidney

Sigdel, T.K. et al.

J Clin Med. 2018 Dec 23;8(1). pii: E19.

Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients

In summary, we have developed and analytically validated a clinical-grade NGS test to measure the fraction of dd-cfDNA in plasma of solid organ transplant patients. This test is applicable to single-organ donor-recipient pairs and does not depend on separate determination of either donor or recipient genotypes...

Grskovic, M.

J Mol Diagn. 2016 Nov;18(6):890-902.

 
Publications: 2014 - Prior

© 2017-2019 by Thermo Fisher Scientific Inc.

  • Black LinkedIn Icon
  • Black Twitter Icon